Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul;24(7):1407-1414.
doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.

ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

David T Miller  1 , Kristy Lee  2 , Noura S Abul-Husn  3 , Laura M Amendola  4 , Kyle Brothers  5 , Wendy K Chung  6 , Michael H Gollob  7 , Adam S Gordon  8 , Steven M Harrison  9 , Ray E Hershberger  10 , Teri E Klein  11 , Carolyn Sue Richards  12 , Douglas R Stewart  13 , Christa Lese Martin  14 ; ACMG Secondary Findings Working Group. Electronic address: documents@acmg.net  15
Affiliations
Free article
Editorial

ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

David T Miller et al. Genet Med. 2022 Jul.
Free article
No abstract available

Keywords: Exome sequencing; Genome sequencing; Incidental findings; Secondary findings.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Funding and support listed here did not support development of this document unless included in the Acknowledgments section. N.S.A.-H. was previously employed by the Regeneron Genetics Center, has received an honorarium from Genentech, and is a member of the scientific advisory board of Allelica, Inc. W.K.C. is a member of the scientific advisory board of Regeneron Genetics Center. D.T.M. has received honoraria from Ambry Genetics and PreventionGenetics LLC. D.R.S. is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute, Rockville, MD, United States, and also performs contract clinical telehealth services for Genome Medical, Inc in accordance with relevant National Cancer Institute ethics policies. All other authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

  • Pharmacogenetics in Italy: current landscape and future prospects.
    Floris M, Moschella A, Alcalay M, Montella A, Tirelli M, Fontana L, Idda ML; Pharmacogenomics Working Group of the Italian Society of Human Genetics (SIGU); Guarnieri P, Capasso M, Mammì C, Nicoletti P, Miozzo M. Floris M, et al. Hum Genomics. 2024 Jul 10;18(1):78. doi: 10.1186/s40246-024-00612-w. Hum Genomics. 2024. PMID: 38987819 Free PMC article. Review.
  • Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
    Keller RB, Mazor T, Sholl L, Aguirre AJ, Singh H, Sethi N, Bass A, Nagaraja AK, Brais LK, Hill E, Hennessey C, Cusick M, Del Vecchio Fitz C, Zwiesler Z, Siegel E, Ovalle A, Trukhanov P, Hansel J, Shapiro GI, Abrams TA, Biller LH, Chan JA, Cleary JM, Corsello SM, Enzinger AC, Enzinger PC, Mayer RJ, McCleary NJ, Meyerhardt JA, Ng K, Patel AK, Perez KJ, Rahma OE, Rubinson DA, Wisch JS, Yurgelun MB, Hassett MJ, MacConaill L, Schrag D, Cerami E, Wolpin BM, Nowak JA, Giannakis M. Keller RB, et al. JCO Precis Oncol. 2023 Jan;7:e2200342. doi: 10.1200/PO.22.00342. JCO Precis Oncol. 2023. PMID: 36634297 Free PMC article.
  • Spectrum of Rare and Common Genetic Variants in Arrhythmogenic Cardiomyopathy Patients.
    Lippi M, Chiesa M, Ascione C, Pedrazzini M, Mushtaq S, Rovina D, Riggio D, Di Blasio AM, Biondi ML, Pompilio G, Colombo GI, Casella M, Novelli V, Sommariva E. Lippi M, et al. Biomolecules. 2022 Jul 28;12(8):1043. doi: 10.3390/biom12081043. Biomolecules. 2022. PMID: 36008935 Free PMC article.
  • The GenoVA study: Equitable implementation of a pragmatic randomized trial of polygenic-risk scoring in primary care.
    Vassy JL, Brunette CA, Lebo MS, MacIsaac K, Yi T, Danowski ME, Alexander NVJ, Cardellino MP, Christensen KD, Gala M, Green RC, Harris E, Jones NE, Kerman BJ, Kraft P, Kulkarni P, Lewis ACF, Lubitz SA, Natarajan P, Antwi AA. Vassy JL, et al. Am J Hum Genet. 2023 Nov 2;110(11):1841-1852. doi: 10.1016/j.ajhg.2023.10.001. Am J Hum Genet. 2023. PMID: 37922883 Free PMC article. Clinical Trial.
  • Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients.
    Menzel M, Ossowski S, Kral S, Metzger P, Horak P, Marienfeld R, Boerries M, Wolter S, Ball M, Neumann O, Armeanu-Ebinger S, Schroeder C, Matysiak U, Goldschmid H, Schipperges V, Fürstberger A, Allgäuer M, Eberhardt T, Niewöhner J, Blaumeiser A, Ploeger C, Haack TB, Tay TKY, Kelemen O, Pauli T, Kirchner M, Kluck K, Ott A, Renner M, Admard J, Gschwind A, Lassmann S, Kestler H, Fend F, Illert AL, Werner M, Möller P, Seufferlein TTW, Malek N, Schirmacher P, Fröhling S, Kazdal D, Budczies J, Stenzinger A. Menzel M, et al. NPJ Precis Oncol. 2023 Oct 20;7(1):106. doi: 10.1038/s41698-023-00457-x. NPJ Precis Oncol. 2023. PMID: 37864096 Free PMC article.
See all "Cited by" articles

Publication types

LinkOut - more resources